Cargando…
Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading cause of mortality globally. Benefiting from the advantages of early diagnosis and precision medicine, stem cell-based therapies have emerged as promising treatment options for CVDs. However, autologous or allogeneic stem cell transplantation imposes a...
Autores principales: | Ma, Jiahui, Lei, Pengyu, Chen, Haojie, Wang, Lei, Fang, Yimeng, Yan, Xiaoqing, Yang, Qinsi, Peng, Bo, Jin, Libo, Sun, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486024/ https://www.ncbi.nlm.nih.gov/pubmed/36147326 http://dx.doi.org/10.3389/fphar.2022.986683 |
Ejemplares similares
-
The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Mediating Roles of miRNAs and lncRNAs
por: Miao, Chenggui, et al.
Publicado: (2021) -
New Developments in Exosomal lncRNAs in Cardiovascular Diseases
por: Yuan, Zhu, et al.
Publicado: (2021) -
The Roles and Mechanisms of lncRNAs in Liver Fibrosis
por: Wang, Zhifa, et al.
Publicado: (2021) -
Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
por: Chen, Haojie, et al.
Publicado: (2023) -
Exosomal lncRNAs from mesenchymal stem cells as the novel modulators to cardiovascular disease
por: Huang, Ying
Publicado: (2020)